> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Telis Bioscience
- URL: https://www.whiteroseintelligence.com/telis-bioscience/
- Published: 1999-01-03T00:39:00.000Z
- Updated: 2025-01-04T00:41:40.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**Telis Bioscience** is an American biotechnology company based in Cambridge, Massachusetts.

## History

Telis was founded in 2019 by Grigory Khimulya and Kyle Fish.[\[1\]](#fn1)[\[2\]](#fn2)

In December 2021, Telis pivoted to focus on developing a [COVID-19 vaccine](https://www.whiteroseintelligence.com/COVID-19-vaccine) under a new name, [Alvea](https://www.whiteroseintelligence.com/Alvea), which launched in January 2022.[\[3\]](#fn3)

## Organization

Telis received $2 million from [Alameda Research](https://www.whiteroseintelligence.com/Alameda-Research).[\[4\]](#fn4)

### Personnel

| Name             | Position                              | Notes |
| ---------------- | ------------------------------------- | ----- |
| Grigory Khimulya | Co-founder & Chief Executive Officer  | \-    |
| Kyle Fish        | Co-founder & Chief Technology Officer | \-    |

## External links

- [Campfire Wiki](https://www.campfire.wiki/doku.php?id=pharmaceutical%5Fcompanies:telis%5Fbioscience)
- [Crunchbase](https://www.crunchbase.com/organization/telis-bioscience)
- [LinkedIn](https://www.linkedin.com/company/telisbio/)

---

1. *Telis Bioscience - Crunchbase Company Profile & Funding.* Crunchbase. Retrieved March 27, 2023, from <https://www.crunchbase.com/organization/telis-bioscience> [↩︎](#fnref1)
2. Grigory Khimulya \[@grigonomics\]. (2020, September 23). *“Life update: for the past year @fish\_kyle3 and I have been building Telis Bioscience, a venture-backed biotech company in Cambridge, MA engineering high-impact protein therapeutics . We’re hiring! (1/5)”* \[Tweet\]. Twitter. <http://archive.today/2023.03.27-011210/https://twitter.com/grigonomics/status/1308768978756567042> [↩︎](#fnref2)
3. McGrath, K. (2022, February 16). *Alvea Launches Scalable, Shelf- Stable DNA Vaccine Development against New SARS-CoV-2 Variants.* PR Newswire. <https://web.archive.org/web/20220513024500/https://www.prnewswire.com/news-releases/alvea-launches-scalable-shelf--stable-dna-vaccine-development-against-new-sars-cov-2-variants-301483557.html> [↩︎](#fnref3)
4. Ashworth, L. (2022, December 19). *How to spend a million dollars, by Sam Bankman-Fried.* Financial Times. <http://archive.today/2023.01.11-055404/https://www.ft.com/content/9a3b4b78-b18b-4d1f-b28b-05a73525aa61> [↩︎](#fnref4)